These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 29428470

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The in vitro pharmacology and non-clinical cardiovascular safety studies of a novel 5-HT4 receptor agonist, DSP-6952.
    Tsubouchi T, Kunimatsu T, Tsujimoto S, Kiyoshi A, Katsura Y, Oku S, Chihara K, Mine Y, Yamada T, Shimizu I, Bando K.
    Eur J Pharmacol; 2018 May 05; 826():96-105. PubMed ID: 29501863
    [Abstract] [Full Text] [Related]

  • 3. Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity.
    Hoffman JM, Tyler K, MacEachern SJ, Balemba OB, Johnson AC, Brooks EM, Zhao H, Swain GM, Moses PL, Galligan JJ, Sharkey KA, Greenwood-Van Meerveld B, Mawe GM.
    Gastroenterology; 2012 Apr 05; 142(4):844-854.e4. PubMed ID: 22226658
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The novel, potent and highly selective 5-HT4 receptor agonist YH12852 significantly improves both upper and lower gastrointestinal motility.
    Jeong EJ, Chung SY, Hong HN, Oh SW, Sim JY.
    Br J Pharmacol; 2018 Feb 05; 175(3):485-500. PubMed ID: 29139561
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Involvement of 5-HT3 and 5-HT4 receptors in colonic motor patterns in rats.
    Yu Y, Chen JH, Li H, Yang Z, Du X, Hong L, Liao H, Jiang L, Shi J, Zhao L, Tan S, Luo H, Huizinga JD.
    Neurogastroenterol Motil; 2015 Jul 05; 27(7):914-28. PubMed ID: 25807879
    [Abstract] [Full Text] [Related]

  • 11. Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial.
    Foxx-Orenstein AE, Camilleri M, Szarka LA, McKinzie S, Burton D, Thomforde G, Baxter K, Zinsmeister AR.
    Neurogastroenterol Motil; 2007 Oct 05; 19(10):821-30. PubMed ID: 17539894
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro.
    Mine Y, Yoshikawa T, Oku S, Nagai R, Yoshida N, Hosoki K.
    J Pharmacol Exp Ther; 1997 Dec 05; 283(3):1000-8. PubMed ID: 9399969
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
    Scarpignato C, Pelosini I.
    Can J Gastroenterol; 1999 Mar 05; 13 Suppl A():50A-65A. PubMed ID: 10202210
    [Abstract] [Full Text] [Related]

  • 16. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
    Gale JD.
    Adv Ther; 2009 May 05; 26(5):519-30. PubMed ID: 19444393
    [Abstract] [Full Text] [Related]

  • 17. Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon.
    Spohn SN, Bianco F, Scott RB, Keenan CM, Linton AA, O'Neill CH, Bonora E, Dicay M, Lavoie B, Wilcox RL, MacNaughton WK, De Giorgio R, Sharkey KA, Mawe GM.
    Gastroenterology; 2016 Nov 05; 151(5):933-944.e3. PubMed ID: 27480173
    [Abstract] [Full Text] [Related]

  • 18. The effects of prucalopride on postoperative ileus in guinea pigs.
    Park SJ, Choi EJ, Yoon YH, Park H.
    Yonsei Med J; 2013 Jul 05; 54(4):845-53. PubMed ID: 23709417
    [Abstract] [Full Text] [Related]

  • 19. Tegaserod: a serotonin 5-HT4 receptor agonist for treatment of constipation-predominant irritable bowel syndrome.
    Cole P, Rabasseda X.
    Drugs Today (Barc); 2004 Dec 05; 40(12):1013-30. PubMed ID: 15645012
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.